Logotype for Enlivex Therapeutics Ltd

Enlivex Therapeutics (ENLV) investor relations material

Enlivex Therapeutics Registration Filing summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Enlivex Therapeutics Ltd
Registration Filing summary23 Dec, 2025

Company overview and business model

  • Operates a dual business model: clinical-stage immunotherapy development (Allocetra™) and a new digital asset treasury strategy focused on acquiring and managing RAIN tokens.

  • Allocetra™ targets macrophage reprogramming for osteoarthritis and other inflammatory diseases, with recent positive Phase IIa data in knee osteoarthritis.

  • Digital asset treasury strategy involves holding, staking, and utilizing DeFi protocols with RAIN tokens to enhance returns and capital efficiency.

  • RAIN is a governance and utility token for a decentralized prediction markets protocol on Arbitrum, with a deflationary buyback and burn mechanism.

Financial performance and metrics

  • As of September 30, 2025, shareholders' equity was $225.7 million (as adjusted for the private placement), with total capitalization of $226.1 million.

  • The private placement increased authorized share capital to 500,000,000 ordinary shares, with 234,401,601 shares outstanding as of September 30, 2025 (as adjusted).

  • Excludes options, RSUs, and warrants that could further dilute share count.

Use of proceeds and capital allocation

  • No proceeds from the resale of shares by selling shareholders; company will receive only $1,891.23 from the exercise of pre-funded warrants if fully exercised.

  • Proceeds from prior private placement used to acquire RAIN tokens and support digital asset treasury strategy.

  • Treasury reserves are highly concentrated in RAIN, with a portion kept liquid for clinical operations and obligations.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Enlivex Therapeutics earnings date

Logotype for Enlivex Therapeutics Ltd
Q1 20258 Jan, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Enlivex Therapeutics earnings date

Logotype for Enlivex Therapeutics Ltd
Q1 20258 Jan, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Enlivex Therapeutics Ltd is an Israel-based clinical-stage biopharmaceutical company focused on developing allogeneic cell therapies for life-threatening immune-related diseases. The company’s lead investigational product is designed to modulate the immune system to restore immune balance in conditions such as sepsis, solid tumors, and other inflammatory disorders. Enlivex conducts clinical trials and research to advance its immunotherapy platform. The company is headquartered in Nes Ziona, Israel, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage